ERIC SCHREADER: Open Payments
NPI 1235816653 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,032 in 27 payments from 18 companies in 2025. Trend: 2023 $1,824 · 2024 $1,238 · 2025 $3,032
Food & beverage: $3,032
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $500 |
| Axsome Therapeutics, Inc. | 3 | $278 |
| GENZYME CORPORATION | 2 | $258 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $224 |
| Smith+Nephew, Inc. | 3 | $195 |
| Boston Scientific Corporation | 1 | $152 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Pharmacosmos Therapeutics Inc. | 1 | $145 |
| TG Therapeutics, Inc. | 1 | $137 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
Products named: OTEZLA, Symbravo, XIFAXAN, Bone Anchors with Arthroscopic Delivery System, WATCHMAN FLX, REZDIFFRA, MONOFERRIC, BRIUMVI.
Industry payments across NY — which companies pay providers there.
